• Healwell posted Q2-2026 revenue of CAD 33 million, down 1% year over year.
• IFRS net income from continuing operations swung to CAD 6.4 million from a loss a year earlier.
• IFRS gross profit fell 4% to CAD 17.9 million; gross margin narrowed 2 percentage points to 54%.
• Operating cash flow for the first half was CAD 4.5 million versus cash used a year earlier.
• SpaceX stake valued at about CAD 23 million; plans to monetize post lock-up to bolster liquidity, targeting ~10% adjusted EBITDA margin by year-end.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healwell Al Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608061605NEWSFILECNPR____20260806_308441_1) on August 06, 2026, and is solely responsible for the information contained therein.